Net Deals Web Search

Search results

  1. Results From The WOW.Com Content Network
  2. Novartis, Viatris face new lawsuit over 'HeLa' cell misuse claims

    www.aol.com/news/novartis-viatris-face-lawsuit...

    Novartis and Viatris were hit with a federal lawsuit in Maryland on Monday by the family of a woman whose tissue cells were taken from her body in the 1950s and used to fuel medical research and ...

  3. Novartis loses initial bid to block generic of best-selling ...

    www.aol.com/news/novartis-loses-initial-bid...

    August 12, 2024 at 3:58 PM. By Blake Brittain. (Reuters) - Novartis failed to convince a Delaware federal court to block generic drugmaker MSN Pharmaceuticals from launching its own version of ...

  4. Why Novartis Stock Is Down Today Despite Topping Q2 ... - AOL

    www.aol.com/finance/why-novartis-stock-down...

    Novartis turned $12.5 billion worth of revenue into per-share earnings of $1.97 in Q2, topping expectations for a profit of $1.89 per share on sales of a little less than $12.4 billion. Better ...

  5. Novartis Gene Therapies - Wikipedia

    en.wikipedia.org/wiki/Novartis_Gene_Therapies

    Novartis Gene Therapies, until 2020 known as AveXis, is a biotechnology company that develops treatments for rare neurological genetic disorders. It was founded in Dallas , Texas , United States in 2012 by John Carbona after reorganizing a company called BioLife Cell Bank founded by David Genecov and John Harkey.

  6. Elanco - Wikipedia

    en.wikipedia.org/wiki/Elanco

    Elanco Animal Health Incorporated is an American pharmaceutical company which produces medicines and vaccinations for pets and livestock. Until 2019, the company was a subsidiary of Eli Lilly and Company, before being divested. It is the third-largest animal health company in the world. [3]

  7. Sanofi - Wikipedia

    en.wikipedia.org/wiki/Sanofi

    Sanofi was founded in 1973 [5] as a subsidiary of Elf Aquitaine (a French oil company subsequently acquired by Total), when Elf Aquitaine took control of the Labaz group, a pharmaceutical company formed in 1947 by SociƩte Belge de l'Azote et des Produits Chimiques du Marly; [6] Labaz developed benziodarone in 1957.

  8. US FDA approves Novartis' kidney disease drug - AOL

    www.aol.com/news/us-fda-approves-novartis-kidney...

    By Sriparna Roy. (Reuters) -The U.S. Food and Drug Administration has approved the use of Novartis' drug to reduce excess protein in the urine of patients with a type of kidney disease, the health ...

  9. Brolucizumab - Wikipedia

    en.wikipedia.org/wiki/Brolucizumab

    Brolucizumab was designed to attach to and block a substance called vascular endothelial growth factor A (VEGF-A). [6] VEGF-A is a protein that makes blood vessels grow and leak fluid and blood, damaging the macula. By blocking VEGF-A, brolucizumab reduces the growth of the blood vessels and controls the leakage and swelling.